AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...

In A Nutshell Vaccinated adults over 70 showed cellular markers of slower aging compared to unvaccinated peers, including ...

A simple guardrail that works for most people: have it after a wholesome meal, not on an empty stomach. It supports appetite ...

Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, ...

Bayer going after Pfizer for patent infringement is a forerunner for abuse of intellectual property claims in food and ...

Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, ...

The relationship between inflammation and cancer represents one of the central paradoxes in modern tumor immunology. On one hand, chronic inflammation is a ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...

Immusoft’s MPS 1 CGT therapeutic hurdles traditional barriers, eliminating patient preconditioning and enabling redosing.

Despite priding himself on understanding how to thrive as a middle-aged cyclist, Phil Cavell was perilously unaware of the ...